KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

TherapeuticsMD (TXMD) Shares Outstanding (2016 - 2025)

TherapeuticsMD (TXMD) has disclosed Shares Outstanding for 4 consecutive years, with $11.5 million as the latest value for Q2 2024.

  • For the quarter ending Q2 2024, Shares Outstanding rose 9.05% year-over-year to $11.5 million, compared with a TTM value of $11.5 million through Jun 2024, up 9.05%, and an annual FY2023 reading of $11.5 million, up 21.42% over the prior year.
  • Shares Outstanding was $11.5 million for Q2 2024 at TherapeuticsMD, roughly flat from $11.5 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $11.5 million in Q4 2023 and bottomed at $8.6 million in Q4 2021.
  • Average Shares Outstanding over 4 years is $10.5 million, with a median of $10.6 million recorded in 2023.
  • The sharpest move saw Shares Outstanding rose 21.42% in 2023, then grew 9.05% in 2024.
  • Year by year, Shares Outstanding stood at $8.6 million in 2021, then rose by 10.48% to $9.5 million in 2022, then increased by 21.42% to $11.5 million in 2023, then changed by 0.0% to $11.5 million in 2024.
  • Business Quant data shows Shares Outstanding for TXMD at $11.5 million in Q2 2024, $11.5 million in Q1 2024, and $11.5 million in Q4 2023.